Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

AGM Update

25 Mar 2020 07:00

RNS Number : 4605H
Premier Veterinary Group PLC
25 March 2020
 

 

 

PREMIER VETERINARY GROUP PLC

 

("PVG", the "Company" or the "Group")

 

2020 Annual General Meeting postponement

 

 

 

London, UK, 25 March 2020 - Premier Veterinary Group PLC (LSE: PVG) today announces that due to the current Coronavirus epidemic, and in line with recent Government advice to limit unnecessary travel and maintain social distancing, the Board of Directors has decided that it would be inappropriate to hold its 2020 Annual General Meeting on 31 March 2020 as communicated to shareholders on 18 February 2020. The previously announced venue for the AGM is now inaccessible and alternatives are proving impractical and equally high risk to arrange under current circumstances.

Article 62 of the Company's Articles of Association provides discretion for the Board of Directors in relation to the postponement of general meetings, in the event that the holding of such a meeting would be impractical or unreasonable. After due and serious consideration the Board has decided that in order to protect the health and safety of its shareholders the 2020 Annual General Meeting must be postponed until such time as it is safe for the Company's shareholders to attend.

Any further changes to this position or notification of the new date for the 2020 Annual General Meeting will be announced in due course and can be found on the Company's web site www.premiervetgroup.co.uk

 

-Ends-

 

For further information, please contact:

 

Premier Veterinary Group plc

Dominic Tonner, Chief Executive Officer Tel: +44 (0)117 970 4130

Andrew Paull, Chief Financial Officer

 

For further details go to: www.premiervetgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAPPUAAWUPUGMC
Date   Source Headline
17th May 201010:17 amRNSForm 8.5 (EPT/NON-RI)
14th May 201011:16 amRNSForm 8.5 (EPT/RI)
14th May 20109:36 amRNSForm 8.5 (EPT/NON-RI)
12th May 201010:39 amRNSForm 8.5 (EPT/RI)
12th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
11th May 20108:41 amRNSForm 8.5 (EPT/NON-RI)
10th May 20104:19 pmRNSForm 8.3 - [Ark Therapeutics Grp]
10th May 201010:41 amRNSForm 8.5 (EPT/NON-RI)
7th May 20102:37 pmRNSForm 8.3 - Ark Therapeutics Grp
7th May 201010:03 amRNSForm 8.5 (EPT/RI)
7th May 201010:01 amRNSForm 8.5 (EPT/NON-RI)
6th May 201012:24 pmRNSForm 8.3 - Ark Therapeutics Group PLC
6th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
5th May 201011:48 amRNSForm 8.3 - (Ark Therapeutics)
5th May 20107:00 amRNSStrategic Review
4th May 20101:54 pmRNSForm 8 (OPD) Ark Therapeutics Group
4th May 20101:36 pmRNSForm 8.5 (EPT/NON-RI)
30th Apr 20101:43 pmRNSForm 8.3 - Ark Therapeutics Group PLC
30th Apr 201012:05 pmRNSTotal Voting Rights
30th Apr 201012:03 pmRNSDirector/PDMR Shareholding
30th Apr 201011:55 amRNSForm 8 (DD) - Ark Therapeutics Group PLC
30th Apr 201010:49 amRNSForm 8.5 (EPT/RI)
29th Apr 201011:11 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 201011:04 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
28th Apr 201010:31 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201011:40 amRNSForm 8.5 (EPT/RI)
26th Apr 20102:53 pmRNSForm 8.3 - ARK THERAPEUTICS
26th Apr 201012:43 pmRNSForm 8.3 - Ark Therapeutics Group plc
26th Apr 201011:30 amRNSForm 8.5 (EPT/RI)
26th Apr 20109:42 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 201011:43 amRNSForm 8.3 - ARK THERAPEUTICS
23rd Apr 201011:36 amRNSForm 8.5 (EPT/RI)
23rd Apr 201010:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 201011:33 amRNSForm 8.3 - ARK THERAPEUTICS
22nd Apr 201011:03 amRNSForm 8.3 - Ark Therapeutics Group Plc
22nd Apr 20109:48 amRNSForm 8.5 (EPT/RI)
21st Apr 20101:47 pmRNSForm 8.3 - ARK THERAPEUTICS
21st Apr 201012:05 pmRNSResult of AGM
21st Apr 20109:11 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20103:56 pmRNSForm 8.3 - Ark Therapeutics Group Plc
20th Apr 201012:49 pmBUSForm 8.3 - Ark Therapeutics Group plc
20th Apr 201011:37 amRNSForm 8.5 (EPT/RI)
20th Apr 20109:48 amRNSForm 8.3 - Ark Therapeutics Plc
20th Apr 20108:53 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
19th Apr 201011:31 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20107:00 amRNSResearch Update
16th Apr 201010:32 amRNSEPT Disclosure
16th Apr 20109:32 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.